Search Authority

What Medicines Does Pfizer Make? Top Drugs & Treatments

Pfizer is a global research-driven biopharmaceutical company focused on discovering, developing, and delivering medicines that help patients around the world. The question what...

Mara Ellison
What Medicines Does Pfizer Make? Top Drugs & Treatments

Pfizer is a global research-driven biopharmaceutical company focused on discovering, developing, and delivering medicines that help patients around the world. The question what medicines do pfizer make spans vaccines, innovative therapies, and public health initiatives that reach into hospitals, clinics, and community settings.

Its portfolio targets some of the most complex diseases, from respiratory viruses to cancer, supported by rigorous science and large-scale global operations. Below is a structured overview of key therapeutic areas and real-world impact.

Therapeutic Area Key Pfizer Medicine Primary Use Approval Status
Oncology Palbociclib (Ibrance) Breast cancer, advanced hormone-positive, HER2-negative FDA and global approvals
Oncology Rituximab (Rituxan) Non-Hodgkin lymphoma, chronic lymphocytic leukemia FDA and global approvals
Infectious Disease Comirnaty (COVID-19 vaccine) Prevention of COVID-19 Emergency and full authorization worldwide
Inflammatory Disease Xeljanz (tofacitinib) Moderate to severe rheumatoid arthritis, psoriatic arthritis FDA and global approvals
Rare Disease Elrexfio (belzutifan) Von Hippel-Lindau disease-related renal cell carcinoma FDA approval

Oncology Portfolio and Targeted Therapies

Pfizer’s oncology medicines are designed to interfere with specific pathways that allow cancer cells to grow and spread. These treatments are often used in combination with surgery, radiation, or other systemic therapies to improve survival and quality of life.

Key Oncology Medicines

  • Palbociclib (Ibrance) for hormone-positive breast cancer
  • Rituximab (Rituxan) for blood cancers and autoimmune conditions
  • Abemaciclib (Verzenio) for certain breast and lung cancers

Vaccines and Infectious Disease Innovation

The company invests heavily in vaccines and antivirals, with a strong focus on pandemic preparedness and respiratory diseases. Its vaccines aim to protect individuals and communities from severe infectious diseases through robust immune responses.

Leading Infectious Disease Products

  • Comirnaty (COVID-19 vaccine) for wide age groups
  • Pneumococcal vaccines to prevent pneumonia and meningitis
  • Research programs targeting influenza and respiratory syncytial virus

Inflammatory and Autoimmune Conditions

For patients with chronic inflammatory conditions, Pfizer offers small molecule and biologic therapies that help reduce inflammation, preserve joint function, and limit disease flares. These treatments are often tailored to individual disease patterns and responses.

Treatments for Inflammatory Diseases

  • Xeljanz (tofacitinib) for rheumatoid arthritis and related conditions
  • Alternative small molecule options for patients who cannot tolerate biologics
  • Ongoing research into psoriasis and immune-mediated disorders

Rare Diseases and Gene Therapy

Rare diseases represent a significant unmet medical need, and Pfizer is building a dedicated portfolio in this space. These therapies target the root genetic causes, aiming to halt or reverse disease progression with long-lasting effects.

Examples in Rare Disease

  • Elrexfio (belzutifan) for von Hippel-Lindau disease
  • Collaborations with gene therapy leaders to develop novel curative approaches
  • Patient support programs to improve access and outcomes

Global Reach and Future Medicine Development

Through advanced research sites and partnerships, Pfizer shapes how new medicines are discovered, tested, and delivered across diverse populations. Its focus on safety, efficacy, and accessibility continues to drive innovation in treatment for many complex diseases.

  • Oncology, vaccines, and rare diseases are core pillars of its portfolio
  • Strong global infrastructure supports clinical trials and distribution
  • Collaborations accelerate development of next-generation therapies
  • Commitment to transparency, real-world data, and patient outcomes
  • Ongoing investment in science that addresses unmet medical needs

FAQ

Reader questions

What types of diseases do Pfizer medicines treat?

Pfizer medicines treat a wide range of conditions, including cancer, infectious diseases such as COVID-19, inflammatory and autoimmune disorders, and rare genetic diseases.

Are Pfizer vaccines part of its medicine portfolio?

Yes, vaccines like Comirnaty are central to Pfizer’s portfolio, representing a key part of its medicines portfolio alongside therapeutic drugs.

Does Pfizer develop treatments for chronic conditions like arthritis?

Yes, it offers small molecule drugs like Xeljanz for rheumatoid arthritis and related inflammatory conditions.

What is Pfizer’s commitment to rare disease medicines?

Pfizer has built a dedicated rare disease portfolio, with therapies like Elrexfio that target specific genetic causes and aim to transform patient lives.

Related Reading

More pages in this topic cluster.

Brigand (Fire Emblem):角色 profile 与战斗指南

在 Fire Emblem 系列中,Brigand 是一种以近战物理为特色的敌我通用职业,通常使用刀剑或斧头,偏向高机动与中等攻击的组合。相较于 Sw...

Read next
Cleo in King's Raid:角色背景、定位与养成指南

Cleo 是 King's Raid 中以机动性与持续输出见长的角色,主要承担副输出或功能型前锋职责。她在队伍中的核心价值体现在灵活切入战场、...

Read next
Oldest Ice Skater: Defying Age on the Ice

The title of oldest ice skater often refers to dieners who have competed or performed well into their eighties and nineties. These athletes combine decades of training with bala...

Read next